Venlo, the Netherlands, June 05, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its new digital PCR (dPCR) Custom Assay Design Tool for copy ...
NEWARK, Del., Jan. 15, 2026 /PRNewswire/ -- As the global healthcare landscape moves toward a personalized, data-driven future, the demand for high-precision diagnostic tools is reaching an all-time ...
Quanterix specializes in ultra-sensitive digital immunoassay platforms for early disease detection, potentially transforming disease management. The company's financials show promising growth, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results